ArticleMedicine2020

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.